Company / Net Income
Veracyte, Inc. Net Income History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$66.4M
FY2025
5-year range
-$75.6M / $66.4M
FY2021-FY2025
Trend
+174.9%
vs FY2024
Sector context
#72 of 158
Health Care
What the data says
At $66M, Veracyte, Inc.'s net income ranks #72 of 158 in the Health Care sector. Net Income has fluctuated over the past 8 years, ranging from -$76M in FY2021 to $66M in FY2025.
Based on SEC 10-K filings.
$66M in FY2025.
Improved from -$74M to $66M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#72 of 158 in Health CareTop 46% of 158This company $66.4M Sector average $458.6M
▼
-85.5% below sector average
Key checks
Key Insights
- In FY2025, net income increased 174.9% year-over-year.
- Ranks #72 out of 158 companies in the Health Care sector.
- Lowest net income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 6.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $66.4M | +174.9% |
| FY2024 | $24.1M | +132.4% |
| FY2023 | -$74.4M | -103.5% |
| FY2022 | -$36.6M | +51.6% |
| FY2021 | -$75.6M | -116.5% |
| FY2020 | -$34.9M | -177.1% |
| FY2019 | -$12.6M | +45.2% |
| FY2018 | -$23.0M | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026